BioSyent Inc. (RX.V)
CAD 11.64
(-0.94%)
CAD 11.64
(-0.94%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -3.68 Million CAD | 43.04% |
| 2022 | -6.46 Million CAD | 60.74% |
| 2021 | -16.47 Million CAD | 11.32% |
| 2020 | -18.58 Million CAD | -60.35% |
| 2019 | -11.58 Million CAD | 31.15% |
| 2018 | -16.83 Million CAD | -33.04% |
| 2017 | -12.65 Million CAD | 3.1% |
| 2016 | -13.05 Million CAD | -197.23% |
| 2015 | -4.39 Million CAD | 37.15% |
| 2014 | -6.98 Million CAD | -59.53% |
| 2013 | -4.38 Million CAD | -89.16% |
| 2012 | -2.31 Million CAD | -118.9% |
| 2011 | -1.05 Million CAD | -124.59% |
| 2010 | -471.09 Thousand CAD | -9.36% |
| 2009 | -430.78 Thousand CAD | 44.95% |
| 2008 | -782.51 Thousand CAD | 27.4% |
| 2007 | -1.07 Million CAD | -2.62% |
| 2006 | -1.05 Million CAD | -345.07% |
| 2005 | -235.96 Thousand CAD | -162.73% |
| 2004 | -89.81 Thousand CAD | 51.03% |
| 2003 | -183.41 Thousand CAD | 56.15% |
| 2002 | -418.29 Thousand CAD | -198.4% |
| 2001 | 425.08 Thousand CAD | 783.13% |
| 2000 | -62.22 Thousand CAD | 79.26% |
| 1999 | -300 Thousand CAD | 0.0% |
| 1998 | - CAD | -100.0% |
| 1997 | 100 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -3.78 Million CAD | -2.81% |
| 2024 Q2 | -8.17 Million CAD | -181.61% |
| 2023 Q3 | -8.4 Million CAD | -5.14% |
| 2023 Q4 | -3.68 Million CAD | 56.13% |
| 2023 Q1 | -5.06 Million CAD | 21.69% |
| 2023 FY | -3.68 Million CAD | 43.04% |
| 2023 Q2 | -7.98 Million CAD | -57.7% |
| 2022 Q4 | -6.46 Million CAD | 4.39% |
| 2022 Q2 | -4.83 Million CAD | 71.21% |
| 2022 Q3 | -6.76 Million CAD | -40.05% |
| 2022 FY | -6.46 Million CAD | 60.74% |
| 2022 Q1 | -16.78 Million CAD | -1.84% |
| 2021 Q1 | -17.3 Million CAD | 6.87% |
| 2021 FY | -16.47 Million CAD | 11.32% |
| 2021 Q3 | -17.19 Million CAD | -22.69% |
| 2021 Q2 | -14.01 Million CAD | 19.02% |
| 2021 Q4 | -16.47 Million CAD | 4.17% |
| 2020 Q1 | -15.83 Million CAD | -36.6% |
| 2020 FY | -18.58 Million CAD | -60.35% |
| 2020 Q3 | -16.41 Million CAD | -29.78% |
| 2020 Q2 | -12.64 Million CAD | 20.11% |
| 2020 Q4 | -18.58 Million CAD | -13.22% |
| 2019 Q3 | -8.83 Million CAD | 18.17% |
| 2019 Q4 | -11.58 Million CAD | -31.13% |
| 2019 Q2 | -10.8 Million CAD | 19.24% |
| 2019 Q1 | -13.37 Million CAD | 20.55% |
| 2019 FY | -11.58 Million CAD | 31.15% |
| 2018 Q3 | -11.41 Million CAD | -131.45% |
| 2018 Q4 | -16.83 Million CAD | -47.46% |
| 2018 FY | -16.83 Million CAD | -33.04% |
| 2018 Q1 | -2.55 Million CAD | 79.81% |
| 2018 Q2 | -4.93 Million CAD | -93.08% |
| 2017 FY | -12.65 Million CAD | 3.1% |
| 2017 Q2 | -10.51 Million CAD | 21.28% |
| 2017 Q3 | -12.32 Million CAD | -17.24% |
| 2017 Q4 | -12.65 Million CAD | -2.67% |
| 2017 Q1 | -13.35 Million CAD | -2.28% |
| 2016 Q4 | -13.05 Million CAD | -19.51% |
| 2016 FY | -13.05 Million CAD | -197.23% |
| 2016 Q3 | -10.92 Million CAD | -9.49% |
| 2016 Q1 | -2.07 Million CAD | 52.78% |
| 2016 Q2 | -9.97 Million CAD | -381.03% |
| 2015 Q4 | -4.39 Million CAD | 3.2% |
| 2015 Q1 | -5.74 Million CAD | 17.85% |
| 2015 Q2 | -5.97 Million CAD | -4.1% |
| 2015 Q3 | -4.53 Million CAD | 24.08% |
| 2015 FY | -4.39 Million CAD | 37.15% |
| 2014 Q4 | -6.98 Million CAD | -8.29% |
| 2014 Q2 | -4.83 Million CAD | -27.56% |
| 2014 Q3 | -6.45 Million CAD | -33.6% |
| 2014 FY | -6.98 Million CAD | -59.53% |
| 2014 Q1 | -3.78 Million CAD | 13.56% |
| 2013 FY | -4.38 Million CAD | -89.16% |
| 2013 Q3 | -3.18 Million CAD | -20.96% |
| 2013 Q4 | -4.38 Million CAD | -37.74% |
| 2013 Q1 | -2.12 Million CAD | 8.32% |
| 2013 Q2 | -2.62 Million CAD | -23.84% |
| 2012 Q4 | -2.31 Million CAD | -19.58% |
| 2012 Q3 | -1.93 Million CAD | -72.73% |
| 2012 Q2 | -1.12 Million CAD | -5.88% |
| 2012 FY | -2.31 Million CAD | -118.9% |
| 2012 Q1 | -1.05 Million CAD | -0.09% |
| 2011 FY | -1.05 Million CAD | -124.59% |
| 2011 Q4 | -1.05 Million CAD | -27.95% |
| 2011 Q3 | -826.92 Thousand CAD | -76.16% |
| 2011 Q2 | -469.42 Thousand CAD | -9.07% |
| 2011 Q1 | -430.38 Thousand CAD | 8.64% |
| 2010 Q4 | -471.09 Thousand CAD | -10.29% |
| 2010 FY | -471.09 Thousand CAD | -9.36% |
| 2010 Q1 | -228.49 Thousand CAD | 46.96% |
| 2010 Q2 | -230.23 Thousand CAD | -0.76% |
| 2010 Q3 | -427.14 Thousand CAD | -85.52% |
| 2009 Q4 | -430.78 Thousand CAD | 7.46% |
| 2009 Q2 | -345 Thousand CAD | 42.2% |
| 2009 Q3 | -465.53 Thousand CAD | -34.94% |
| 2009 FY | -430.78 Thousand CAD | 44.95% |
| 2009 Q1 | -596.89 Thousand CAD | 23.72% |
| 2008 Q2 | -679.11 Thousand CAD | 18.24% |
| 2008 Q3 | -749.79 Thousand CAD | -10.41% |
| 2008 Q4 | -782.51 Thousand CAD | -4.36% |
| 2008 FY | -782.51 Thousand CAD | 27.4% |
| 2008 Q1 | -830.56 Thousand CAD | 22.94% |
| 2007 Q2 | -33.87 Thousand CAD | 97.14% |
| 2007 Q1 | -1.18 Million CAD | -12.71% |
| 2007 FY | -1.07 Million CAD | -2.62% |
| 2007 Q4 | -1.07 Million CAD | -267.02% |
| 2007 Q3 | -293.65 Thousand CAD | -766.93% |
| 2006 FY | -1.05 Million CAD | -345.07% |
| 2006 Q1 | -240.45 Thousand CAD | -1.9% |
| 2006 Q3 | -281.72 Thousand CAD | -32.62% |
| 2006 Q2 | -212.42 Thousand CAD | 11.66% |
| 2006 Q4 | -1.05 Million CAD | -272.78% |
| 2005 FY | -235.96 Thousand CAD | -162.73% |
| 2005 Q2 | -854.39 Thousand CAD | -20.3% |
| 2005 Q1 | -710.2 Thousand CAD | -690.76% |
| 2005 Q3 | -865.19 Thousand CAD | -1.26% |
| 2005 Q4 | -235.96 Thousand CAD | 72.73% |
| 2004 Q4 | -89.81 Thousand CAD | 11.88% |
| 2004 Q3 | -101.92 Thousand CAD | 41.99% |
| 2004 Q2 | -175.71 Thousand CAD | -17.92% |
| 2004 Q1 | -149 Thousand CAD | 18.76% |
| 2004 FY | -89.81 Thousand CAD | 51.03% |
| 2003 Q4 | -183.41 Thousand CAD | 36.57% |
| 2003 FY | -183.41 Thousand CAD | 56.15% |
| 2003 Q3 | -289.17 Thousand CAD | -37.86% |
| 2003 Q2 | -209.75 Thousand CAD | 3.18% |
| 2003 Q1 | -216.65 Thousand CAD | 48.21% |
| 2002 FY | -418.29 Thousand CAD | -198.4% |
| 2002 Q1 | -623.65 Thousand CAD | -246.71% |
| 2002 Q2 | -472.92 Thousand CAD | 24.17% |
| 2002 Q3 | -514.15 Thousand CAD | -8.72% |
| 2002 Q4 | -418.29 Thousand CAD | 18.64% |
| 2001 Q3 | -16.25 Thousand CAD | 52.87% |
| 2001 Q4 | 425.08 Thousand CAD | 2714.76% |
| 2001 FY | 425.08 Thousand CAD | 783.13% |
| 2001 Q1 | -9783.00 CAD | 84.28% |
| 2001 Q2 | -34.49 Thousand CAD | -252.58% |
| 2000 Q4 | -62.22 Thousand CAD | -3.37% |
| 2000 FY | -62.22 Thousand CAD | 79.26% |
| 2000 Q2 | 500 Thousand CAD | 600.0% |
| 2000 Q3 | -60.19 Thousand CAD | -112.04% |
| 2000 Q1 | -100 Thousand CAD | 66.67% |
| 1999 FY | -300 Thousand CAD | 0.0% |
| 1999 Q1 | 100 Thousand CAD | 0.0% |
| 1999 Q3 | 100 Thousand CAD | -50.0% |
| 1999 Q4 | -300 Thousand CAD | -400.0% |
| 1999 Q2 | 200 Thousand CAD | 100.0% |
| 1998 Q2 | -200 Thousand CAD | -200.0% |
| 1998 Q3 | -100 Thousand CAD | 50.0% |
| 1998 Q1 | 200 Thousand CAD | 100.0% |
| 1998 Q4 | - CAD | 100.0% |
| 1998 FY | - CAD | -100.0% |
| 1997 FY | 100 Thousand CAD | 0.0% |
| 1997 Q3 | -100 Thousand CAD | 0.0% |
| 1997 Q4 | 100 Thousand CAD | 200.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 4.89 Million CAD | 175.302% |
| CanadaBis Capital Inc. | 4.08 Million CAD | 190.227% |
| Decibel Cannabis Company Inc. | 37.48 Million CAD | 109.831% |
| Delivra Health Brands Inc. | -2.17 Million CAD | -69.58% |
| Entourage Health Corp. | 150.32 Million CAD | 102.451% |
| Lifeist Wellness Inc. | -188.12 Thousand CAD | -1858.746% |
| Cannara Biotech Inc. | 41.51 Million CAD | 108.877% |
| Medicure Inc. | -5.82 Million CAD | 36.739% |
| PharmaCielo Ltd. | 18.24 Million CAD | 120.195% |
| Rubicon Organics Inc. | 475.37 Thousand CAD | 875.176% |
| Voyageur Pharmaceuticals Ltd. | 37.91 Thousand CAD | 9819.027% |